FAST NEWS: Antengene appoints Hansoh to commercialize myeloma drug
The latest: Antengene Corporation Ltd. (6996.HK) announced Friday it has entered into an exclusive collaboration agreement with Hansoh Pharmaceutical Group Co. Ltd. (3692.HK) for the commercialization of the relapse or…
FAST NEWS: Antengene Corporation Announces First Ever Revenue of $7.8 Million
The latest: Antengene Corp. Ltd. (6996.HK), a biopharmaceutical company, announced Thursday it expects revenue for the six months ended June 30 this year to range from 53 million yuan ($7.8…
RELATED ARTICLES
-
Cancer drug maker Genfleet joins Hong Kong IPO influx
-
Tsui Wah goes to college as consumers dine out less
1314.HK
-
BRIEF: Hua Hong Semi appoints former Intel VP as new president
1347.HK 688347.SHG
-
Ultraman lifts Bloks Group to new heights in first post-IPO report
0325.HK
-
Everest gets boost from core product Nefecon’s inclusion in China’s national health plan
1952.HK
